Redeems $40 Million of its 6.625% Senior Secured Notes due 2025, and Increases its Quarterly Cash Dividend to $0.45 Per Share Redeems $40 Million of its 6.625% Senior Secured Notes due 2025, and Increases its Quarterly Cash Dividend to $0.45 Per Share
Organizations must align their culture to the importance of mental health, emotional needs, physical health, financial well-being and work/life balance. They also need to re-evaluate how technology can support these five areas. Organizations must align their culture to the importance…
TORONTO, Feb. 04, 2023 (GLOBE NEWSWIRE) — AGF Management Limited (“AGF”) announced today that the Toronto Stock Exchange (“TSX”) has approved AGF’s notice of intention to renew its normal course issuer bid in respect of its Class B Non-Voting Shares…
Reports fourth quarter 2023 revenue of $11.9 million, GAAP diluted EPS of $0.31 and non-GAAP diluted EPS of $0.33 Announces full-year and first quarter 2023 financial guidance WINTER SPRINGS, Fla., Feb. 04, 2023 (GLOBE NEWSWIRE) — iRadimed Corporation (the “Company”)…
DUBLIN, Feb. 4, 2023 /PRNewswire/ — The “LiDAR for Automotive Patent Landscape 2023” report has been added to ResearchAndMarkets.com’s offering. Report’s Key Features: PDF with > 140 slides Excel file > 11.900 patent families and hyperlink to an updated online…
SAN FRANCISCO, Feb. 03, 2023 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema,” “Olema Oncology” or the “Company,” Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers, today announced that the…
Hofseth BioCare ASA (“HBC”) had gross operating revenues of NOK 26.1m (23.1m) in the fourth quarter and total operating revenues of NOK 87.6m (69.3) for the full year. Cost of sales (CoGS) amounted to NOK 20.9m (16.7m) in the quarter…
Market Dynamics Factors such as technological advances in bronchoscopy, the increasing prevalence of lung cancer and pulmonary diseases, and the expanding applications of bronchoscopy will drive the growth of the bronchoscopes market. However, the high cost of bronchoscopy might hamper…
MIAMI, Feb. 03, 2023 (GLOBE NEWSWIRE) — Global Crossing Airlines Group, Inc. (JET: TSX-V; JET.B: TSX-V; JETMF: OTCQB) (the “Company” or “GlobalX”) today announces that, on February 3, 2023 the Company filed a Form 8-A Registration Statement (“Form 8-A”) with…
The Yara International ASA fourth quarter 2023 results will be published on Tuesday 8 February 2022 at 08:00 CET. An on-line presentation will be held at 12:00 CET, hosted by Yara President and CEO Svein Tore Holsether. The presentation will…
